Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07668674Phase 2Not yet recruiting
Phase 2 trial (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Resting-state anterior insula activity measured by functional MRI (BOLD signal amplitude) at 30 days. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07668674.